nsv491525
- Organism: Homo sapiens
- Study:nstd45 (ClinGen Curated Dosage Sensitivity Map-obsoleted)
- Variant Type:copy number variation
- Method Type:
- Submitted on:GRCh37 (hg19)
- Variant Calls:0
- Validation:Not tested
- Clinical Assertions: No
- Region Size:4,631,880
- Description:
15q11q13 recurrent (PWS/AS) region (BP2-BP3, Class 2) - Publication(s):Christian et al. 1995, Christian et al. 2008, Cook et al. 1997, Jacquemont et al. 2006, Kim et al. 2012, Riggs et al. 2011
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 14201 SVs from 123 studies. See in: genome view
Overlapping variant regions from other studies: 14205 SVs from 123 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nsv491525 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000015.10 | Chr15 | 23,502,849 | 28,134,728 |
nsv491525 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000015.9 | Chr15 | 23,747,996 | 28,379,874 |
Variant Call Information
Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | Copy number |
---|---|---|---|---|---|---|---|
nssv1184536 | copy number loss | Curated | Curated | ANGELMAN SYNDROME; AS | Pathogenic | ClinGen Dosage Sensitivity Map | 1 |
nssv1184537 | copy number loss | Curated | Curated | PRADER-WILLI SYNDROME; PWS | Pathogenic | ClinGen Dosage Sensitivity Map | 1 |
nssv3442742 | copy number gain | Curated | Curated | CHROMOSOME 15q11-q13 DUPLICATION SYNDROME | Pathogenic | ClinGen Dosage Sensitivity Map | 3 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nssv1184536 | Remapped | Perfect | NC_000015.10:g.(?_ 23502849)_(2813472 8_?)del | GRCh38.p12 | First Pass | NC_000015.10 | Chr15 | 23,502,849 | 28,134,728 |
nssv1184537 | Remapped | Perfect | NC_000015.10:g.(?_ 23502849)_(2813472 8_?)del | GRCh38.p12 | First Pass | NC_000015.10 | Chr15 | 23,502,849 | 28,134,728 |
nssv3442742 | Remapped | Perfect | NC_000015.10:g.(?_ 23502849)_(2813472 8_?)dup | GRCh38.p12 | First Pass | NC_000015.10 | Chr15 | 23,502,849 | 28,134,728 |
nssv1184536 | Submitted genomic | NC_000015.9:g.(?_2 3747996)_(28379874 _?)del | GRCh37 (hg19) | NC_000015.9 | Chr15 | 23,747,996 | 28,379,874 | ||
nssv1184537 | Submitted genomic | NC_000015.9:g.(?_2 3747996)_(28379874 _?)del | GRCh37 (hg19) | NC_000015.9 | Chr15 | 23,747,996 | 28,379,874 | ||
nssv3442742 | Submitted genomic | NC_000015.9:g.(?_2 3747996)_(28379874 _?)dup | GRCh37 (hg19) | NC_000015.9 | Chr15 | 23,747,996 | 28,379,874 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | HGVS | Type | Allele Origin | Subject Phenotype | Clinical Interpretation | Source of Interpretation | Copy number |
---|---|---|---|---|---|---|---|
nssv1184536 | GRCh37: NC_000015.9:g.(?_23747996)_(28379874_?)del | copy number loss | maternal | ANGELMAN SYNDROME; AS | Pathogenic | ClinGen Dosage Sensitivity Map | 1 |
nssv1184537 | GRCh37: NC_000015.9:g.(?_23747996)_(28379874_?)del | copy number loss | paternal | PRADER-WILLI SYNDROME; PWS | Pathogenic | ClinGen Dosage Sensitivity Map | 1 |
nssv3442742 | GRCh37: NC_000015.9:g.(?_23747996)_(28379874_?)dup | copy number gain | maternal | CHROMOSOME 15q11-q13 DUPLICATION SYNDROME | Pathogenic | ClinGen Dosage Sensitivity Map | 3 |